Some studies revealed that ZIC2 could regulate the progression of several types of cancer, including nasopharyngeal carcinoma (Shen et al. 2017), bladder cancer (Wang et al. 2017), and liver cancer (Zhu et al. 2015). Here, ZIC2 is linked to urinary bladder carcinoma.